BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 14568947)

  • 1. M cell DNA vaccination for CTL immunity to HIV.
    Wang X; Hone DM; Haddad A; Shata MT; Pascual DW
    J Immunol; 2003 Nov; 171(9):4717-25. PubMed ID: 14568947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.
    Kaneko H; Bednarek I; Wierzbicki A; Kiszka I; Dmochowski M; Wasik TJ; Kaneko Y; Kozbor D
    Virology; 2000 Feb; 267(1):8-16. PubMed ID: 10648178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
    Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
    J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity.
    Belyakov IM; Moss B; Strober W; Berzofsky JA
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4512-7. PubMed ID: 10200293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.
    Belyakov IM; Derby MA; Ahlers JD; Kelsall BL; Earl P; Moss B; Strober W; Berzofsky JA
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1709-14. PubMed ID: 9465081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of novel type I interferon epsilon in viral infection and mucosal immunity.
    Xi Y; Day SL; Jackson RJ; Ranasinghe C
    Mucosal Immunol; 2012 Nov; 5(6):610-22. PubMed ID: 22617838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity.
    Shata MT; Hone DM
    J Virol; 2001 Oct; 75(20):9665-70. PubMed ID: 11559798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein.
    Wierzbicki A; Kiszka I; Kaneko H; Kmieciak D; Wasik TJ; Gzyl J; Kaneko Y; Kozbor D
    Vaccine; 2002 Jan; 20(9-10):1295-307. PubMed ID: 11818148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses.
    Santra S; Barouch DH; Jackson SS; Kuroda MJ; Schmitz JE; Lifton MA; Sharpe AH; Letvin NL
    J Immunol; 2000 Dec; 165(12):6791-5. PubMed ID: 11120800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges.
    Khattar SK; Manoharan V; Bhattarai B; LaBranche CC; Montefiori DC; Samal SK
    mBio; 2015 Jul; 6(4):e01005. PubMed ID: 26199332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.
    Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M
    J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
    Shinoda K; Xin KQ; Jounai N; Kojima Y; Tamura Y; Okada E; Kawamoto S; Okuda K; Klinman D; Okuda K
    Vaccine; 2004 Sep; 22(27-28):3676-90. PubMed ID: 15315847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A novel immunization strategy to induce strong humoral responses against HIV-1 using combined DNA, recombinant vaccinia virus and protein vaccines].
    Liu C; Wang SH; Ren L; Hao YL; Zhang QC; Liu Y
    Bing Du Xue Bao; 2014 Nov; 30(6):645-51. PubMed ID: 25868279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HIV env immunities elicited by nucleic acid vaccines.
    Shiver JW; Davies ME; Yasutomi Y; Perry HC; Freed DC; Letvin NL; Liu MA
    Vaccine; 1997 Jun; 15(8):884-7. PubMed ID: 9234539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen.
    Allen TM; Vogel TU; Fuller DH; Mothé BR; Steffen S; Boyson JE; Shipley T; Fuller J; Hanke T; Sette A; Altman JD; Moss B; McMichael AJ; Watkins DI
    J Immunol; 2000 May; 164(9):4968-78. PubMed ID: 10779808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity.
    Hinkula J
    Expert Rev Vaccines; 2007 Apr; 6(2):203-12. PubMed ID: 17408370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.
    Belyakov IM; Wyatt LS; Ahlers JD; Earl P; Pendleton CD; Kelsall BL; Strober W; Moss B; Berzofsky JA
    J Virol; 1998 Oct; 72(10):8264-72. PubMed ID: 9733870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O.
    Bu Z; Ye L; Skeen MJ; Ziegler HK; Compans RW; Yang C
    AIDS Res Hum Retroviruses; 2003 May; 19(5):409-20. PubMed ID: 12803999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.